Davies Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-951
Closed -$217K 12
2025
Q4
$217K Sell
951
-1,581
-62% -$360K 0.4% 44
2025
Q3
$586K Sell
2,532
-214
-8% -$43.6K 0.48% 45
2025
Q2
$510K Sell
2,746
-12
-0.4% -$2.23K 0.4% 52
2025
Q1
$578K Sell
2,758
-49
-2% -$9.53K 0.49% 41
2024
Q4
$499K Sell
2,807
-676
-19% -$124K 0.42% 45
2024
Q3
$688K Sell
3,483
-696
-17% -$130K 0.6% 37
2024
Q2
$717K Sell
4,179
-227
-5% -$37.6K 0.67% 34
2024
Q1
$802K Buy
+4,406
New +$759K 0.82% 31

Other funds holding ABBV

Davies Financial Advisors's ABBV Position: Q1 2026 in Review

Davies Financial Advisors sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 951 shares — an estimated $217K sold.

Davies Financial Advisors first reported a position in ABBV in Q1 2024 and held it in 8 quarters. The position peaked at $802K in Q1 2024. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Davies Financial Advisors reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Davies Financial Advisors sold 951 AbbVie shares in Q1 2026, an estimated $217K.
  • Davies Financial Advisors first reported a position in AbbVie in Q1 2024 and held it in 8 quarters.
  • Davies Financial Advisors's AbbVie position peaked at $802K in Q1 2024.
  • 4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Davies Financial Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.